NOV | NOVNYSEEnergyCommon stock golden cross and death cross projections, cross tests and history

$18.49
-$0.19 (-1.02%)

NOV (NOV) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Nov 2025, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $18.49 vs 50 $19.86 / 200 $19.67
Projection
Death cross projected in 6 bars
Test
No active test
Last cross
Golden cross 5 Nov 2025 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $19.29 vs 50 $19.02 / 200 $17.50
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 10 Aug 2026 ยท projected 30 bars out ยท tested 1 bar

4-hour as of 3 Nov 13:30 ET

Price
below both $18.83 vs 50 $19.10 / 200 $19.76
Projection
No cross projected
Test
No active test
Last cross
Death cross 9 Oct 2026 ยท projected 30 bars out

Cross history

35
crosses on record since 2018
18 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
9 Oct 2026Death4-hour30 bars outNot tested
12 Aug 2026Golden4-hour11 bars outNot tested
week of 10 Aug 2026Golden moderateweekly30 bars out1 bar cross test
7 Jul 2026Death4-hour25 bars outNot tested
5 Nov 2025Golden moderatedaily25 bars outNot tested

About NOV

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$62.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorEnergy
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.